Combination of anticholinergics and inhibitors of phosphodiesterase type 4 for the treatment of respiratory disease
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jan 17, 2012
Grant Date -
May 28, 2009
app pub date -
Feb 3, 2009
filing date -
Feb 6, 2004
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The present invention relates to a combination of an inhaled/oral PDE 4 inhibitor in combination with inhaled anticholinergic bronchodilators (muscarinic receptor antagonists), preferentially Roflumilast or AWD-12-281 and R,R-glycopyrrolate, for symptomatic or prophylactic treatment of respiratory diseases, especially those accompanied by obstruction or inflammation such as chronic obstructive pulmonary disease (COPD) or asthma. It further comprises the presentation of this combination in a locally applied (inhaled) formulation and application in an inhalation device for instance in the Novolizer®.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully